LIMES Schlosskliniken Past Earnings Performance
Past criteria checks 2/6
LIMES Schlosskliniken has been growing earnings at an average annual rate of 49.8%, while the Healthcare industry saw earnings growing at 10.6% annually. Revenues have been growing at an average rate of 33.5% per year. LIMES Schlosskliniken's return on equity is 23.2%, and it has net margins of 10.2%.
Key information
49.8%
Earnings growth rate
49.8%
EPS growth rate
Healthcare Industry Growth | 15.7% |
Revenue growth rate | 33.5% |
Return on equity | 23.2% |
Net Margin | 10.2% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How LIMES Schlosskliniken makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 42 | 4 | 8 | 0 |
31 Mar 24 | 39 | 4 | 7 | 0 |
31 Dec 23 | 37 | 3 | 7 | 0 |
30 Sep 23 | 33 | 3 | 6 | 0 |
30 Jun 23 | 30 | 3 | 5 | 0 |
31 Mar 23 | 29 | 4 | 4 | 0 |
31 Dec 22 | 29 | 4 | 4 | 0 |
30 Sep 22 | 29 | 4 | 4 | 0 |
30 Jun 22 | 29 | 4 | 4 | 0 |
31 Mar 22 | 26 | 4 | 4 | 0 |
31 Dec 21 | 23 | 4 | 4 | 0 |
30 Sep 21 | 19 | 3 | 3 | 0 |
30 Jun 21 | 15 | 2 | 3 | 0 |
31 Mar 21 | 13 | 0 | 3 | 0 |
31 Dec 20 | 11 | -1 | 2 | 0 |
30 Sep 20 | 10 | -1 | 1 | 0 |
30 Jun 20 | 9 | -1 | 0 | 0 |
31 Mar 20 | 9 | -1 | 0 | 0 |
31 Dec 19 | 8 | -1 | 0 | 0 |
30 Sep 19 | 8 | -1 | 0 | 0 |
30 Jun 19 | 8 | -1 | 1 | 0 |
31 Mar 19 | 8 | -1 | 1 | 0 |
31 Dec 18 | 8 | -1 | 1 | 0 |
31 Dec 17 | 7 | -1 | 2 | 0 |
Quality Earnings: LIK has a high level of non-cash earnings.
Growing Profit Margin: LIK's current net profit margins (10.2%) are lower than last year (11%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: LIK has become profitable over the past 5 years, growing earnings by 49.8% per year.
Accelerating Growth: LIK's earnings growth over the past year (31.8%) is below its 5-year average (49.8% per year).
Earnings vs Industry: LIK earnings growth over the past year (31.8%) did not outperform the Healthcare industry 40.5%.
Return on Equity
High ROE: LIK's Return on Equity (23.2%) is considered high.